TY - JOUR
T1 - Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation
T2 - A morphological and molecular study
AU - Corradi, Domenico
AU - Callegari, Sergio
AU - Maestri, Roberta
AU - Ferrara, David
AU - Mangieri, Domenica
AU - Alinovi, Rossella
AU - Mozzoni, Paola
AU - Pinelli, Silvana
AU - Goldoni, Matteo
AU - Privitera, Ylenia Adelaide
AU - Bartoli, Veronica
AU - Astorri, Ettore
AU - MacChi, Emilio
AU - Vaglio, Augusto
AU - Benussi, Stefano
AU - Alfieri, Ottavio
PY - 2012/3
Y1 - 2012/3
N2 - Introduction: Atrial fibrillation (AF) in mitral regurgitation (MR) is a complex disease where multiple factors may induce left-atrial structural remodeling (SR). We explored the differential SR of the left-atrial posterior wall (LAPW) of patients affected by MR with or without persistent AF, and the expression of key proteins involved in its pathogenesis. Methods and Results: Light microscopy of LAPW samples from 27 patients with MR and persistent AF (group 1), 33 with MR in sinus rhythm (group 2), and 15 autopsy controls (group 3) was used to measure myocyte diameter, percentage of myocytolytic myocytes, interstitial fibrosis, and capillary density; RT-PCR and Western blotting were used to assess the mRNA and protein levels of SOD-1, SOD-2, HO-1, calpain, MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGF; immunofluorescence was used to locate these proteins. Myocyte diameter was similar in groups 1 and 2, but larger than controls. Compared to group 2, group 1 had more myocytolytic myocytes (20.8 ± 5.6% vs 14.7 ± 4.5%; P <0.0001), increased interstitial fibrosis (10.4 ± 5.1% vs 7.5 ± 4.2%; P <0.05), and decreased capillary density (923 ± 107 No/mm 2 vs 1,040 ± 100 No/mm 2; P <0.0001). All of the proteins were more expressed in groups 1 and 2 than in controls. The protein and mRNA levels of SOD-1, SOD-2, MMP-2, and MMP-9 were higher in group 1 than in group 2. Conclusions: The LAPW of MR patients with or without AF shows considerable SR. The former has more severe histopathological changes and higher levels of proteins involved in SR, thereby reaching a threshold beyond which the sinus impulse cannot normally activate atrial myocardium.
AB - Introduction: Atrial fibrillation (AF) in mitral regurgitation (MR) is a complex disease where multiple factors may induce left-atrial structural remodeling (SR). We explored the differential SR of the left-atrial posterior wall (LAPW) of patients affected by MR with or without persistent AF, and the expression of key proteins involved in its pathogenesis. Methods and Results: Light microscopy of LAPW samples from 27 patients with MR and persistent AF (group 1), 33 with MR in sinus rhythm (group 2), and 15 autopsy controls (group 3) was used to measure myocyte diameter, percentage of myocytolytic myocytes, interstitial fibrosis, and capillary density; RT-PCR and Western blotting were used to assess the mRNA and protein levels of SOD-1, SOD-2, HO-1, calpain, MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGF; immunofluorescence was used to locate these proteins. Myocyte diameter was similar in groups 1 and 2, but larger than controls. Compared to group 2, group 1 had more myocytolytic myocytes (20.8 ± 5.6% vs 14.7 ± 4.5%; P <0.0001), increased interstitial fibrosis (10.4 ± 5.1% vs 7.5 ± 4.2%; P <0.05), and decreased capillary density (923 ± 107 No/mm 2 vs 1,040 ± 100 No/mm 2; P <0.0001). All of the proteins were more expressed in groups 1 and 2 than in controls. The protein and mRNA levels of SOD-1, SOD-2, MMP-2, and MMP-9 were higher in group 1 than in group 2. Conclusions: The LAPW of MR patients with or without AF shows considerable SR. The former has more severe histopathological changes and higher levels of proteins involved in SR, thereby reaching a threshold beyond which the sinus impulse cannot normally activate atrial myocardium.
KW - atrial fibrillation
KW - inflammation
KW - left atrium
KW - mitral regurgitation
KW - remodeling
UR - http://www.scopus.com/inward/record.url?scp=84858622160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858622160&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8167.2011.02187.x
DO - 10.1111/j.1540-8167.2011.02187.x
M3 - Article
C2 - 21954878
AN - SCOPUS:84858622160
VL - 23
SP - 271
EP - 279
JO - Journal of Cardiovascular Electrophysiology
JF - Journal of Cardiovascular Electrophysiology
SN - 1045-3873
IS - 3
ER -